A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas
Clinical trial NCT03809767 · COMPLETED
Trial details
- NCT number
- NCT03809767
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-29
- Primary completion
- 2021-08-30
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.